ArticleJournal of global health2026
Diagnosis of tuberculous lymphadenopathy: the role of droplet digital PCR.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculous lymphadenopathy (TB-LAP) is the most common form of extrapulmonary TB and remains diagnostically challenging due to its paucibacillary nature. We evaluated the diagnostic performance of droplet digital PCR (ddPCR) for detecting Mycobacterium tuberculosis (Mtb) DNA in formalin-fixed paraffin-embedded (FFPE) lymph node specimens. Methods: We retrospectively analysed 102 lymph node FFPE specimens with microbiologically confirmed or pathology-suspected TB-LAP. We performed ddPCR targeting the IS6110 gene and correlated it with pathological findings and mycobacterial culture results. Diagnostic performance was assessed using receiver operating characteristic analysis. Results: Pathological findings included granulomatous inflammation (GI) (n = 67), caseating GI (CGI) (n = 22), CGI with acid-fast bacilli (AFB) (n = 7), GI with AFB (n = 1), and atypical findings (n = 5). There was a graded association between ddPCR and pathological severity (P for trend = 0.002), with the highest levels in CGI plus AFB and the lowest in non-TB-LAP cases. Mtb DNA concentration (copies/μL) was significantly higher in AFB-positive specimens (mean (x̄) = 22.9, standard deviation (SD) = 61.5) compared with AFB-negative specimens (x̄ = 0.6, SD = 0.8) (P = 0.044). Among 52 specimens sent for mycobacterial culture, 9 (17%) were culture-positive, and these specimens had significantly higher ddPCR values (P = 0.025). Receiver operating characteristic analysis yielded an area under the curve of 0.715 (95% confidence interval = 0.536-0.894) for AFB positivity. Using a cutoff value of >1.25 copies/μL resulted in 50% sensitivity and 86% specificity. Lowering the cutoff to >0.33 copies/μL increased sensitivity to 88%, but reduced specificity to 51%. Conclusions: We found that ddPCR quantitatively detects Mtb DNA in lymph node FFPE specimens and correlates with pathological severity and culture positivity. Although the overall diagnostic accuracy was moderate, ddPCR demonstrated distinct sensitivity and specificity profiles at different cutoff values and may serve as a useful adjunctive diagnostic tool when interpreted in conjunction with clinical and histopathological findings in TB-LAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.